Abstract S6-01: Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+ advanced breast cancer: BOLERO-1

Name: Work Video:
Duration: 3 min 30 s
Sara A. Hurvitz; Fabrice André; Zefei Jiang; Zhimin Shao; Silvia P. Neciosup; Max S. Mano; Ling-Min Tseng; Qingyuan Zhang; Kunwei Shen; Donggeng Liu; Lydia Dreosti; Jifeng Feng; Howard A. Burris; Masakazu Toi; Marc Buyse; David Cabaribere; Mark A. Lindsay; Tiffany Kunz; Shantha Rao; Lida Pacaud; Tetiana Taran; Dennis J. Slamon
{'id': 'https://openalex.org/W1559849809', 'doi': 'https://doi.org/10.1158/1538-7445.sabcs14-s6-01', 'title': 'Abstract S6-01: Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+ advanced breast cancer: BOLERO-1', 'display_name': 'Abstract S6-01: Phase 3, randomized, double-blind, placebo-controlled multicenter trial of daily everolimus plus weekly trastuzumab and paclitaxel as first-line therapy in women with HER2+ advanced breast cancer: BOLERO-1', 'publication_year': 2015, 'publication_date': '2015-05-01', 'ids': {'openalex': 'https://openalex.org/W1559849809', 'doi': 'https://doi.org/10.1158/1538-7445.sabcs14-s6-01', 'mag': '1559849809'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.sabcs14-s6-01', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5068059897', 'display_name': 'Sara A. Hurvitz', 'orcid': 'https://orcid.org/0000-0001-7808-7191'}, 'institutions': [{'id': 'https://openalex.org/I2803209242', 'display_name': 'University of California System', 'ror': 'https://ror.org/00pjdza24', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I2803209242']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Sara A Hurvitz', 'raw_affiliation_strings': ['#N#1University of California#N#'], 'affiliations': [{'raw_affiliation_string': '#N#1University of California#N#', 'institution_ids': ['https://openalex.org/I2803209242']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5001814176', 'display_name': 'Fabrice André', 'orcid': 'https://orcid.org/0000-0001-5795-8357'}, 'institutions': [{'id': 'https://openalex.org/I2801843802', 'display_name': 'Institut Gustave Roussy', 'ror': 'https://ror.org/0321g0743', 'country_code': 'FR', 'type': 'facility', 'lineage': ['https://openalex.org/I2801843802']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Fabrice Andre', 'raw_affiliation_strings': ['2Institut Gustave Roussy'], 'affiliations': [{'raw_affiliation_string': '2Institut Gustave Roussy', 'institution_ids': ['https://openalex.org/I2801843802']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5076149259', 'display_name': 'Zefei Jiang', 'orcid': 'https://orcid.org/0000-0002-4295-0173'}, 'institutions': [{'id': 'https://openalex.org/I4210096476', 'display_name': '307th Hospital of Chinese People’s Liberation Army', 'ror': 'https://ror.org/00vrd0936', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210096476']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Zefei Jiang', 'raw_affiliation_strings': ['3Beijing 307 Hospital of PLA'], 'affiliations': [{'raw_affiliation_string': '3Beijing 307 Hospital of PLA', 'institution_ids': ['https://openalex.org/I4210096476']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100744578', 'display_name': 'Zhimin Shao', 'orcid': 'https://orcid.org/0000-0002-4567-7635'}, 'institutions': [{'id': 'https://openalex.org/I24943067', 'display_name': 'Fudan University', 'ror': 'https://ror.org/013q1eq08', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I24943067']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Zhimin Shao', 'raw_affiliation_strings': ['4Cancer Hospital of Fudan University'], 'affiliations': [{'raw_affiliation_string': '4Cancer Hospital of Fudan University', 'institution_ids': ['https://openalex.org/I24943067']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5024747592', 'display_name': 'Silvia P. Neciosup', 'orcid': 'https://orcid.org/0000-0002-2657-9853'}, 'institutions': [{'id': 'https://openalex.org/I4210123325', 'display_name': 'Instituto Nacional de Enfermedades Neoplásicas', 'ror': 'https://ror.org/03674y156', 'country_code': 'PE', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210123325']}], 'countries': ['PE'], 'is_corresponding': False, 'raw_author_name': 'Silvia P Neciosup', 'raw_affiliation_strings': ['5Instituto Nacional de Enfermedades Neoplasicas'], 'affiliations': [{'raw_affiliation_string': '5Instituto Nacional de Enfermedades Neoplasicas', 'institution_ids': ['https://openalex.org/I4210123325']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5071767816', 'display_name': 'Max S. Mano', 'orcid': 'https://orcid.org/0000-0001-5666-5261'}, 'institutions': [{'id': 'https://openalex.org/I4210088998', 'display_name': 'Instituto do Câncer do Estado de São Paulo', 'ror': 'https://ror.org/005vqqr19', 'country_code': 'BR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210088998']}], 'countries': ['BR'], 'is_corresponding': False, 'raw_author_name': 'Max S Mano', 'raw_affiliation_strings': ['6Instituto do Câncer do Estado de São Paulo'], 'affiliations': [{'raw_affiliation_string': '6Instituto do Câncer do Estado de São Paulo', 'institution_ids': ['https://openalex.org/I4210088998']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5051071807', 'display_name': 'Ling-Min Tseng', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210152230', 'display_name': 'Kaohsiung Veterans General Hospital', 'ror': 'https://ror.org/04jedda80', 'country_code': 'TW', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210152230']}, {'id': 'https://openalex.org/I2803004286', 'display_name': 'Taipei Veterans General Hospital', 'ror': 'https://ror.org/03ymy8z76', 'country_code': 'TW', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2803004286']}], 'countries': ['TW'], 'is_corresponding': False, 'raw_author_name': 'Ling-Min Tseng', 'raw_affiliation_strings': ['7Taipei Veterans General Hospital'], 'affiliations': [{'raw_affiliation_string': '7Taipei Veterans General Hospital', 'institution_ids': ['https://openalex.org/I4210152230', 'https://openalex.org/I2803004286']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100741380', 'display_name': 'Qingyuan Zhang', 'orcid': 'https://orcid.org/0000-0001-7618-4393'}, 'institutions': [{'id': 'https://openalex.org/I156144747', 'display_name': 'Harbin Medical University', 'ror': 'https://ror.org/05jscf583', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I156144747']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Qingyuan Zhang', 'raw_affiliation_strings': ['8Tumor Hospital of Harbin Medical University'], 'affiliations': [{'raw_affiliation_string': '8Tumor Hospital of Harbin Medical University', 'institution_ids': ['https://openalex.org/I156144747']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5072445958', 'display_name': 'Kunwei Shen', 'orcid': 'https://orcid.org/0000-0002-1961-8666'}, 'institutions': [{'id': 'https://openalex.org/I2801556517', 'display_name': 'Ruijin Hospital', 'ror': 'https://ror.org/01hv94n30', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I2801556517']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Kunwei Shen', 'raw_affiliation_strings': ['9Ruijin Hospital, Shanghai Jiaotong University School of Medicine'], 'affiliations': [{'raw_affiliation_string': '9Ruijin Hospital, Shanghai Jiaotong University School of Medicine', 'institution_ids': ['https://openalex.org/I2801556517']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5006325289', 'display_name': 'Donggeng Liu', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I157773358', 'display_name': 'Sun Yat-sen University', 'ror': 'https://ror.org/0064kty71', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I157773358']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Donggeng Liu', 'raw_affiliation_strings': ['#N#10Sun Yat-sen University Cancer Center#N#'], 'affiliations': [{'raw_affiliation_string': '#N#10Sun Yat-sen University Cancer Center#N#', 'institution_ids': ['https://openalex.org/I157773358']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5000513331', 'display_name': 'Lydia Dreosti', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I69552723', 'display_name': 'University of Pretoria', 'ror': 'https://ror.org/00g0p6g84', 'country_code': 'ZA', 'type': 'education', 'lineage': ['https://openalex.org/I69552723']}], 'countries': ['ZA'], 'is_corresponding': False, 'raw_author_name': 'Lydia M Dreosti', 'raw_affiliation_strings': ['11University of Pretoria'], 'affiliations': [{'raw_affiliation_string': '11University of Pretoria', 'institution_ids': ['https://openalex.org/I69552723']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5100728900', 'display_name': 'Jifeng Feng', 'orcid': 'https://orcid.org/0000-0002-7979-2391'}, 'institutions': [{'id': 'https://openalex.org/I154093214', 'display_name': 'Xinjiang Medical University', 'ror': 'https://ror.org/01p455v08', 'country_code': 'CN', 'type': 'education', 'lineage': ['https://openalex.org/I154093214']}, {'id': 'https://openalex.org/I4210102015', 'display_name': 'Tumor Hospital of Xinjiang Medical University', 'ror': 'https://ror.org/015tqbb95', 'country_code': 'CN', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210102015']}], 'countries': ['CN'], 'is_corresponding': False, 'raw_author_name': 'Jifeng Feng', 'raw_affiliation_strings': ['12Jiangsu Provincial Tumor Hospital'], 'affiliations': [{'raw_affiliation_string': '12Jiangsu Provincial Tumor Hospital', 'institution_ids': ['https://openalex.org/I154093214', 'https://openalex.org/I4210102015']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5072308451', 'display_name': 'Howard A. Burris', 'orcid': 'https://orcid.org/0000-0002-1501-2931'}, 'institutions': [{'id': 'https://openalex.org/I172427033', 'display_name': 'Sarah Cannon Research Institute', 'ror': 'https://ror.org/03cp5cj42', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I172427033']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'Howard A Burris', 'raw_affiliation_strings': ['13Sarah Cannon Research Institute'], 'affiliations': [{'raw_affiliation_string': '13Sarah Cannon Research Institute', 'institution_ids': ['https://openalex.org/I172427033']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5091245889', 'display_name': 'Masakazu Toi', 'orcid': 'https://orcid.org/0000-0003-1488-9958'}, 'institutions': [{'id': 'https://openalex.org/I22299242', 'display_name': 'Kyoto University', 'ror': 'https://ror.org/02kpeqv85', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I22299242']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Masakazu Toi', 'raw_affiliation_strings': ['14Graduate School of Medicine, Kyoto University'], 'affiliations': [{'raw_affiliation_string': '14Graduate School of Medicine, Kyoto University', 'institution_ids': ['https://openalex.org/I22299242']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5085474533', 'display_name': 'Marc Buyse', 'orcid': 'https://orcid.org/0000-0002-4559-0994'}, 'institutions': [{'id': 'https://openalex.org/I4210157644', 'display_name': 'International Drug Development', 'ror': 'https://ror.org/056thpa20', 'country_code': 'FR', 'type': 'other', 'lineage': ['https://openalex.org/I4210157644']}, {'id': 'https://openalex.org/I4210101853', 'display_name': 'International Drug Development Institute (Belgium)', 'ror': 'https://ror.org/016dg3e07', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I4210101853']}], 'countries': ['BE', 'FR'], 'is_corresponding': False, 'raw_author_name': 'Marc E Buyse', 'raw_affiliation_strings': ['15International Drug Development Institute'], 'affiliations': [{'raw_affiliation_string': '15International Drug Development Institute', 'institution_ids': ['https://openalex.org/I4210157644', 'https://openalex.org/I4210101853']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5038740056', 'display_name': 'David Cabaribere', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210110449', 'display_name': 'Translational Research in Oncology', 'ror': 'https://ror.org/01yqkfx81', 'country_code': 'FR', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210110449']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'David Cabaribere', 'raw_affiliation_strings': ['16Translational Research in Oncology (TRIO)'], 'affiliations': [{'raw_affiliation_string': '16Translational Research in Oncology (TRIO)', 'institution_ids': ['https://openalex.org/I4210110449']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5040482894', 'display_name': 'Mark A. Lindsay', 'orcid': 'https://orcid.org/0000-0003-4807-5506'}, 'institutions': [{'id': 'https://openalex.org/I4210110449', 'display_name': 'Translational Research in Oncology', 'ror': 'https://ror.org/01yqkfx81', 'country_code': 'FR', 'type': 'nonprofit', 'lineage': ['https://openalex.org/I4210110449']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Mary-Ann Lindsay', 'raw_affiliation_strings': ['17Translational Research in Oncology (TRIO)'], 'affiliations': [{'raw_affiliation_string': '17Translational Research in Oncology (TRIO)', 'institution_ids': ['https://openalex.org/I4210110449']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5057485618', 'display_name': 'Tiffany Kunz', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1283582996', 'display_name': 'Novartis (Switzerland)', 'ror': 'https://ror.org/02f9zrr09', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Tiffany Kunz', 'raw_affiliation_strings': ['18Novartis Pharmaceuticals Corporation'], 'affiliations': [{'raw_affiliation_string': '18Novartis Pharmaceuticals Corporation', 'institution_ids': ['https://openalex.org/I1283582996']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5047856318', 'display_name': 'Shantha Rao', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1283582996', 'display_name': 'Novartis (Switzerland)', 'ror': 'https://ror.org/02f9zrr09', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Shantha Rao', 'raw_affiliation_strings': ['18Novartis Pharmaceuticals Corporation'], 'affiliations': [{'raw_affiliation_string': '18Novartis Pharmaceuticals Corporation', 'institution_ids': ['https://openalex.org/I1283582996']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5048369262', 'display_name': 'Lida Pacaud', 'orcid': 'https://orcid.org/0000-0002-7803-2366'}, 'institutions': [{'id': 'https://openalex.org/I1283582996', 'display_name': 'Novartis (Switzerland)', 'ror': 'https://ror.org/02f9zrr09', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Lida B Pacaud', 'raw_affiliation_strings': ['18Novartis Pharmaceuticals Corporation'], 'affiliations': [{'raw_affiliation_string': '18Novartis Pharmaceuticals Corporation', 'institution_ids': ['https://openalex.org/I1283582996']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5113735301', 'display_name': 'Tetiana Taran', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I1283582996', 'display_name': 'Novartis (Switzerland)', 'ror': 'https://ror.org/02f9zrr09', 'country_code': 'CH', 'type': 'company', 'lineage': ['https://openalex.org/I1283582996']}], 'countries': ['CH'], 'is_corresponding': False, 'raw_author_name': 'Tetiana Taran', 'raw_affiliation_strings': ['18Novartis Pharmaceuticals Corporation'], 'affiliations': [{'raw_affiliation_string': '18Novartis Pharmaceuticals Corporation', 'institution_ids': ['https://openalex.org/I1283582996']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5015491002', 'display_name': 'Dennis J. Slamon', 'orcid': 'https://orcid.org/0000-0002-6330-498X'}, 'institutions': [{'id': 'https://openalex.org/I2803209242', 'display_name': 'University of California System', 'ror': 'https://ror.org/00pjdza24', 'country_code': 'US', 'type': 'education', 'lineage': ['https://openalex.org/I2803209242']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Dennis Slamon', 'raw_affiliation_strings': ['#N#1University of California#N#'], 'affiliations': [{'raw_affiliation_string': '#N#1University of California#N#', 'institution_ids': ['https://openalex.org/I2803209242']}]}], 'institution_assertions': [], 'countries_distinct_count': 11, 'institutions_distinct_count': 20, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 2.424, 'has_fulltext': False, 'cited_by_count': 10, 'citation_normalized_percentile': {'value': 0.679106, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 86, 'max': 87}, 'biblio': {'volume': '75', 'issue': '9_Supplement', 'first_page': 'S6', 'last_page': '01'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12829', 'display_name': 'Advanced Breast Cancer Therapies', 'score': 0.9818, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12829', 'display_name': 'Advanced Breast Cancer Therapies', 'score': 0.9818, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11752', 'display_name': 'Cancer Treatment and Pharmacology', 'score': 0.9514, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10952', 'display_name': 'PI3K/AKT/mTOR signaling in cancer', 'score': 0.9502, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/everolimus', 'display_name': 'Everolimus', 'score': 0.8132788}, {'id': 'https://openalex.org/keywords/taxane', 'display_name': 'Taxane', 'score': 0.7244825}, {'id': 'https://openalex.org/keywords/clinical-endpoint', 'display_name': 'Clinical endpoint', 'score': 0.5162125}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.8652564}, {'id': 'https://openalex.org/C2779699572', 'wikidata': 'https://www.wikidata.org/wiki/Q421052', 'display_name': 'Everolimus', 'level': 2, 'score': 0.8132788}, {'id': 'https://openalex.org/C2777511904', 'wikidata': 'https://www.wikidata.org/wiki/Q425227', 'display_name': 'Taxane', 'level': 4, 'score': 0.7244825}, {'id': 'https://openalex.org/C2779786085', 'wikidata': 'https://www.wikidata.org/wiki/Q412616', 'display_name': 'Trastuzumab', 'level': 4, 'score': 0.6979816}, {'id': 'https://openalex.org/C143998085', 'wikidata': 'https://www.wikidata.org/wiki/Q162555', 'display_name': 'Oncology', 'level': 1, 'score': 0.64217633}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.62561166}, {'id': 'https://openalex.org/C530470458', 'wikidata': 'https://www.wikidata.org/wiki/Q128581', 'display_name': 'Breast cancer', 'level': 3, 'score': 0.5703058}, {'id': 'https://openalex.org/C2908647359', 'wikidata': 'https://www.wikidata.org/wiki/Q2625603', 'display_name': 'Population', 'level': 2, 'score': 0.56170017}, {'id': 'https://openalex.org/C2777292972', 'wikidata': 'https://www.wikidata.org/wiki/Q423762', 'display_name': 'Paclitaxel', 'level': 3, 'score': 0.547942}, {'id': 'https://openalex.org/C2775930923', 'wikidata': 'https://www.wikidata.org/wiki/Q12859063', 'display_name': 'Metastatic breast cancer', 'level': 4, 'score': 0.54378307}, {'id': 'https://openalex.org/C203092338', 'wikidata': 'https://www.wikidata.org/wiki/Q1340863', 'display_name': 'Clinical endpoint', 'level': 3, 'score': 0.5162125}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.41390994}, {'id': 'https://openalex.org/C168563851', 'wikidata': 'https://www.wikidata.org/wiki/Q1436668', 'display_name': 'Randomized controlled trial', 'level': 2, 'score': 0.27105758}, {'id': 'https://openalex.org/C99454951', 'wikidata': 'https://www.wikidata.org/wiki/Q932068', 'display_name': 'Environmental health', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.sabcs14-s6-01', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.81}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W2110444464', 'https://openalex.org/W2103808574'], 'abstract_inverted_index': {'Abstract': [0], 'Background:': [1], 'Everolimus': [2], '(EVE),': [3], 'an': [4], 'inhibitor': [5], 'of': [6, 9, 20, 57, 127, 297, 319], 'mammalian': [7], 'target': [8], 'rapamycin': [10], '(mTOR),': [11], 'is': [12, 50], 'a': [13, 18], 'protein': [14], 'kinase': [15], 'central': [16], 'to': [17, 53, 59, 101, 121], 'number': [19], 'signaling': [21], 'pathways': [22], 'regulating': [23], 'cell': [24], 'growth': [25], 'and': [26, 38, 44, 114, 129, 136, 150, 189, 202, 220, 303], 'proliferation.': [27], 'In': [28, 72, 168], 'early': [29], 'studies,': [30], 'EVE': [31, 58, 104], 'showed': [32], 'antitumor': [33], 'activity': [34], 'in': [35, 94, 109, 131, 137, 163, 215, 308], 'breast': [36, 69, 84, 313], 'cancer': [37, 85], 'synergy': [39], 'with': [40, 81, 111, 310], 'both': [41, 132], 'trastuzumab': [42, 302], '(TRAS)': [43], 'paclitaxel.': [45], 'The': [46, 116, 152, 206], 'international': [47], 'BOLERO-1': [48, 233, 315], 'study': [49], 'being': [51], 'conducted': [52], 'evaluate': [54], 'the': [55, 95, 123, 133, 138, 164, 169, 172, 209, 320], 'addition': [56], 'TRAS': [60, 91, 200], 'plus': [61, 300], 'paclitaxel': [62, 113, 304], 'as': [63, 305], 'first-line': [64, 306], 'therapy': [65, 198, 307], 'for': [66], 'HER2+': [67, 82, 311], 'advanced': [68, 83, 96, 312], 'cancer.': [70], 'Methods:': [71], 'this': [73], 'phase': [74], '3': [75, 193], 'randomized': [76, 99], 'trial,': [77], '719': [78], 'adult': [79], 'women': [80, 309], 'who': [86], 'had': [87, 179, 183, 191], 'not': [88], 'received': [89], 'prior': [90], 'or': [92, 105], 'chemotherapy': [93], 'setting': [97], 'were': [98, 120, 161], '2:1': [100], 'receive': [102], 'either': [103], 'placebo': [106], '(10': [107], 'mg)': [108], 'combination': [110], 'weekly': [112, 301], 'TRAS.': [115], 'two': [117], 'primary': [118], 'objectives': [119], 'compare': [122], 'progression-free': [124], 'survivals': [125], '(PFS)': [126], 'everolimus/trastuzumab/paclitaxel': [128], 'trastuzumab/paclitaxel/placebo': [130], 'full': [134, 165, 170], 'population': [135], 'Hormone': [139], 'Receptor': [140], 'negative': [141], '(HR-)': [142], 'subpopulation.': [143], 'Secondary': [144], 'endpoints': [145, 223], 'included': [146, 199], 'survival,': [147], 'response': [148], 'rate,': [149], 'safety.': [151], 'final': [153, 210], 'analysis': [154, 211], 'was': [155, 175], 'performed': [156], 'after': [157], '420': [158], 'PFS': [159], 'events': [160], 'observed': [162], 'population.': [166], 'Results:': [167], 'population,': [171], 'median': [173], 'age': [174], '53': [176], 'years,': [177], '70.4%': [178], 'visceral': [180], 'metastases,': [181], '56.1%': [182], 'ER': [184], 'and/or': [185], 'PgR': [186], '+ve': [187], 'disease,': [188], '43.3%': [190], '≥': [192], 'metastatic': [194], 'sites.': [195], 'Previous': [196], 'adjuvant': [197], '(11.4%)': [201], 'taxane': [203], '(24.7%).': [204], 'Conclusions:': [205], 'data': [207], 'from': [208], 'will': [212, 224], 'be': [213, 225], 'available': [214], 'October': [216], '2014.': [217, 229], 'PFS,': [218], 'safety,': [219], 'secondary': [221], 'efficacy': [222], 'presented': [226], 'at': [227], 'SABCS': [228], '(Funded': [230], 'by': [231], 'Novartis;': [232], 'ClinicalTrials.gov': [234], 'number,': [235], 'NCT00876395.)': [236], 'Citation': [237], 'Format:': [238], 'Sara': [239], 'A': [240, 268], 'Hurvitz,': [241], 'Fabrice': [242], 'Andre,': [243], 'Zefei': [244], 'Jiang,': [245], 'Zhimin': [246], 'Shao,': [247], 'Silvia': [248], 'P': [249], 'Neciosup,': [250], 'Max': [251], 'S': [252], 'Mano,': [253], 'Ling-Min': [254], 'Tseng,': [255], 'Qingyuan': [256], 'Zhang,': [257], 'Kunwei': [258], 'Shen,': [259], 'Donggeng': [260], 'Liu,': [261], 'Lydia': [262], 'M': [263], 'Dreosti,': [264], 'Jifeng': [265], 'Feng,': [266], 'Howard': [267], 'Burris,': [269], 'Masakazu': [270], 'Toi,': [271], 'Marc': [272], 'E': [273], 'Buyse,': [274], 'David': [275], 'Cabaribere,': [276], 'Mary-Ann': [277], 'Lindsay,': [278], 'Tiffany': [279], 'Kunz,': [280], 'Shantha': [281], 'Rao,': [282], 'Lida': [283], 'B': [284], 'Pacaud,': [285], 'Tetiana': [286], 'Taran,': [287], 'Dennis': [288], 'Slamon.': [289], 'Phase': [290], '3,': [291], 'randomized,': [292], 'double-blind,': [293], 'placebo-controlled': [294], 'multicenter': [295], 'trial': [296], 'daily': [298], 'everolimus': [299], 'cancer:': [314], '[abstract].': [316], 'In:': [317], 'Proceedings': [318], 'Thirty-Seventh': [321], 'Annual': [322], 'CTRC-AACR': [323], 'San': [324, 332], 'Antonio': [325], 'Breast': [326], 'Cancer': [327, 338], 'Symposium:': [328], '2014': [329], 'Dec': [330], '9-13;': [331], 'Antonio,': [333], 'TX.': [334], 'Philadelphia': [335], '(PA):': [336], 'AACR;': [337], 'Res': [339], '2015;75(9': [340], 'Suppl):Abstract': [341], 'nr': [342], 'S6-01.': [343]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1559849809', 'counts_by_year': [{'year': 2017, 'cited_by_count': 1}, {'year': 2016, 'cited_by_count': 3}, {'year': 2015, 'cited_by_count': 6}], 'updated_date': '2024-12-08T11:53:51.359645', 'created_date': '2016-06-24'}
Publication Information

Basic Information

Access and Citation

AI Researcher Chatbot

Primary Location

Authors

Topics

Keywords

Related Works
